Literature DB >> 10333375

Brain metastases.

P Davey1.   

Abstract

The topic of brain metastases has recently become a popular subject for review. The reasons for this most likely include technical advances in therapy, notably radiosurgery, as well as recently-published reports of phase III studies, which have addressed certain aspects of management, notably the combination of surgery and radiotherapy in the treatment of patients with a single metastasis. The main purpose of treatment is to reverse the patient's neurological deficits and prolong life. Nevertheless, opinions remain divided on whether meaningful clinical progress has been achieved overall. A clinician working in a tertiary referral center offering radiosurgery for a selected group of favorable patients may believe that the therapeutic nihilism of the past is no longer warranted, whereas another, whose experience is based on the management of patients dying from metastatic lung cancer, may still question the value of active treatment. The purpose of this review will be to try to reconcile these opinions by providing a critical analysis of the available evidence, identify current problems in management, and suggest future directions for clinical investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333375     DOI: 10.1016/s0147-0272(99)90007-7

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  7 in total

1.  Lung cancer: district active treatment rates affect survival.

Authors:  M L Cartman; A C Hatfield; M F Muers; M D Peake; R A Haward; D Forman
Journal:  J Epidemiol Community Health       Date:  2002-06       Impact factor: 3.710

2.  Surgical treatment for brain metastases: prognostic factors and survival in 177 patients.

Authors:  Andreas M Stark; Hauke Tscheslog; Ralf Buhl; Janka Held-Feindt; H Maximilian Mehdorn
Journal:  Neurosurg Rev       Date:  2004-12-18       Impact factor: 3.042

3.  Predictors for patterns of brain relapse and overall survival in patients with non-small cell lung cancer.

Authors:  Simon Guo-Jeng Tang; Chen-Kan Tseng; Pei-Kwei Tsay; Chih-Hung Chen; John Wen-Cheng Chang; Ping-Chin Pai; Ji-Hong Hong
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

4.  Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.

Authors:  Feng-Ju Huang; Patricia S Steeg; Janet E Price; Wen-Tai Chiu; Ping-Chieh Chou; Keping Xie; Raymond Sawaya; Suyun Huang
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 5.  Brain metastases.

Authors:  P Y Wen; J S Loeffler
Journal:  Curr Treat Options Oncol       Date:  2000-12

Review 6.  Management of metastatic melanoma patients with brain metastases.

Authors:  Martin Majer; Wolfram E Samlowski
Journal:  Curr Oncol Rep       Date:  2007-09       Impact factor: 5.075

7.  Rare incidence of a diffuse brain metastatic carcinoma: A case report.

Authors:  Xiang Sun; Zhijuan Chen; Weidong Yang; Fuhua Yu; Jingwang Zhao; Ping He; Zengguang Wang
Journal:  Oncol Lett       Date:  2014-07-24       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.